GLA gene therapy (Abeona Therapeutics)

N/A

Report date: 2025/01/26 19:33:38

Base Information

Drug NameGLA gene therapy (Abeona Therapeutics)
Drug Alias Namenext-generation AIM AAV vector based GLA gene therapy (Abeona Therapeutics)
ClassificationBiologics
Mechanisms of Actionα-Galactosidase stimulantsα-Galactosidase modulators
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbeona Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A